Foghorn Therapeutics (FHTX) Shares Outstanding (Diluted Average) (2020 - 2025)
Historic Shares Outstanding (Diluted Average) for Foghorn Therapeutics (FHTX) over the last 6 years, with Q3 2025 value amounting to $63.0 million.
- Foghorn Therapeutics' Shares Outstanding (Diluted Average) rose 68.12% to $63.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.0 million, marking a year-over-year increase of 68.12%. This contributed to the annual value of $54.9 million for FY2024, which is 3079.24% up from last year.
- Latest data reveals that Foghorn Therapeutics reported Shares Outstanding (Diluted Average) of $63.0 million as of Q3 2025, which was up 68.12% from $63.0 million recorded in Q2 2025.
- In the past 5 years, Foghorn Therapeutics' Shares Outstanding (Diluted Average) ranged from a high of $63.0 million in Q3 2025 and a low of $36.8 million during Q1 2021
- Its 5-year average for Shares Outstanding (Diluted Average) is $46.4 million, with a median of $41.8 million in 2023.
- As far as peak fluctuations go, Foghorn Therapeutics' Shares Outstanding (Diluted Average) skyrocketed by 57998.69% in 2021, and later soared by 68.12% in 2025.
- Foghorn Therapeutics' Shares Outstanding (Diluted Average) (Quarter) stood at $37.2 million in 2021, then rose by 11.89% to $41.6 million in 2022, then rose by 0.92% to $42.0 million in 2023, then surged by 30.79% to $54.9 million in 2024, then grew by 14.81% to $63.0 million in 2025.
- Its Shares Outstanding (Diluted Average) stands at $63.0 million for Q3 2025, versus $63.0 million for Q2 2025 and $62.8 million for Q1 2025.